Eli Lilly

(Image: Getty/Klebercordeiro)

Lilly expands migraine offerings after FDA approval

By Ben Hargreaves

US FDA gives marketing authorization to Lilly’s oral medication for the acute treatment of migraines in adult patients, adding to its Emgality approval almost exactly a year ago.

Lilly to train Russian FDA

Lilly to train Russian FDA

By Nick Taylor

Eli Lilly is among the organisations partnering to provide training for the Rozdravnadzor, Russia’s equivalent of the FDA, which is seeking to improve its knowledge of manufacturing standards.


Follow us


View more


Featured Suppliers